INSPIRE MEDICAL SYSTEMS INC (INSP) Fundamental Analysis & Valuation

NYSE:INSP • US4577301090

Current stock price

56.7 USD
+0.56 (+1%)
At close:
57.44 USD
+0.74 (+1.31%)
After Hours:

This INSP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. INSP Profitability Analysis

1.1 Basic Checks

  • INSP had positive earnings in the past year.
  • In the past year INSP had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: INSP reported negative net income in multiple years.
  • INSP had a positive operating cash flow in 4 of the past 5 years.
INSP Yearly Net Income VS EBIT VS OCF VS FCFINSP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • INSP has a Return On Assets of 16.03%. This is amongst the best in the industry. INSP outperforms 94.65% of its industry peers.
  • INSP's Return On Equity of 18.62% is amongst the best of the industry. INSP outperforms 91.98% of its industry peers.
  • With a decent Return On Invested Capital value of 5.75%, INSP is doing good in the industry, outperforming 77.01% of the companies in the same industry.
Industry RankSector Rank
ROA 16.03%
ROE 18.62%
ROIC 5.75%
ROA(3y)6.51%
ROA(5y)-0.53%
ROE(3y)7.56%
ROE(5y)-0.94%
ROIC(3y)N/A
ROIC(5y)N/A
INSP Yearly ROA, ROE, ROICINSP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

1.3 Margins

  • Looking at the Profit Margin, with a value of 15.95%, INSP belongs to the top of the industry, outperforming 91.98% of the companies in the same industry.
  • INSP has a Operating Margin of 5.59%. This is in the better half of the industry: INSP outperforms 71.66% of its industry peers.
  • The Gross Margin of INSP (85.39%) is better than 93.58% of its industry peers.
  • INSP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.59%
PM (TTM) 15.95%
GM 85.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.64%
GM growth 5Y0.15%
INSP Yearly Profit, Operating, Gross MarginsINSP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. INSP Health Analysis

2.1 Basic Checks

  • INSP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for INSP has been reduced compared to 1 year ago.
  • The number of shares outstanding for INSP has been increased compared to 5 years ago.
  • INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
INSP Yearly Shares OutstandingINSP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
INSP Yearly Total Debt VS Total AssetsINSP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • INSP has an Altman-Z score of 9.30. This indicates that INSP is financially healthy and has little risk of bankruptcy at the moment.
  • INSP's Altman-Z score of 9.30 is amongst the best of the industry. INSP outperforms 86.63% of its industry peers.
  • There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.3
ROIC/WACC0.64
WACC9.03%
INSP Yearly LT Debt VS Equity VS FCFINSP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • INSP has a Current Ratio of 6.08. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of INSP (6.08) is better than 80.21% of its industry peers.
  • A Quick Ratio of 4.56 indicates that INSP has no problem at all paying its short term obligations.
  • INSP's Quick ratio of 4.56 is fine compared to the rest of the industry. INSP outperforms 77.01% of its industry peers.
Industry RankSector Rank
Current Ratio 6.08
Quick Ratio 4.56
INSP Yearly Current Assets VS Current LiabilitesINSP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. INSP Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 45.09% over the past year.
  • Looking at the last year, INSP shows a quite strong growth in Revenue. The Revenue has grown by 13.60% in the last year.
  • INSP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.20% yearly.
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.87%
Revenue 1Y (TTM)13.6%
Revenue growth 3Y30.76%
Revenue growth 5Y51.2%
Sales Q2Q%12.25%

3.2 Future

  • Based on estimates for the next years, INSP will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.64% on average per year.
  • The Revenue is expected to grow by 8.47% on average over the next years. This is quite good.
EPS Next Y-20.55%
EPS Next 2Y2.59%
EPS Next 3Y11.8%
EPS Next 5Y14.64%
Revenue Next Year6.34%
Revenue Next 2Y7.23%
Revenue Next 3Y8.22%
Revenue Next 5Y8.47%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
INSP Yearly Revenue VS EstimatesINSP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
INSP Yearly EPS VS EstimatesINSP Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4

More info and screens

Find the best growth stocksShow best growing peers

4

4. INSP Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 22.59, INSP is valued on the expensive side.
  • Based on the Price/Earnings ratio, INSP is valued a bit cheaper than the industry average as 75.94% of the companies are valued more expensively.
  • INSP's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.64.
  • The Price/Forward Earnings ratio is 28.43, which means the current valuation is very expensive for INSP.
  • INSP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. INSP is cheaper than 73.26% of the companies in the same industry.
  • INSP is valuated rather expensively when we compare the Price/Forward Earnings ratio to 21.36, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.59
Fwd PE 28.43
INSP Price Earnings VS Forward Price EarningsINSP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • INSP's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. INSP is cheaper than 75.40% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of INSP indicates a rather cheap valuation: INSP is cheaper than 87.17% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.81
EV/EBITDA 17.02
INSP Per share dataINSP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The decent profitability rating of INSP may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.59%
EPS Next 3Y11.8%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INSP Dividend Analysis

5.1 Amount

  • INSP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INSP Fundamentals: All Metrics, Ratios and Statistics

INSPIRE MEDICAL SYSTEMS INC

NYSE:INSP (5/1/2026, 8:04:00 PM)

After market: 57.44 +0.74 (+1.31%)

56.7

+0.56 (+1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength11.18
Industry Growth59.63
Earnings (Last)02-11
Earnings (Next)05-04
Inst Owners120.05%
Inst Owner Change0.44%
Ins Owners1.01%
Ins Owner Change2.32%
Market Cap1.63B
Revenue(TTM)911.98M
Net Income(TTM)145.42M
Analysts72
Price Target87.77 (54.8%)
Short Float %10.16%
Short Ratio2.69
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)176.52%
Min EPS beat(2)81.33%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)151.77%
Min EPS beat(4)81.33%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)214.54%
EPS beat(12)12
Avg EPS beat(12)205.03%
EPS beat(16)16
Avg EPS beat(16)165.1%
Revenue beat(2)0
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-0.7%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-0.7%
Max Revenue beat(4)1.13%
Revenue beat(8)3
Avg Revenue beat(8)0.06%
Revenue beat(12)6
Avg Revenue beat(12)1.03%
Revenue beat(16)10
Avg Revenue beat(16)3.19%
PT rev (1m)-3.94%
PT rev (3m)-35.72%
EPS NQ rev (1m)4.21%
EPS NQ rev (3m)-375.18%
EPS NY rev (1m)0.99%
EPS NY rev (3m)12.8%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-6%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-3.99%
Valuation
Industry RankSector Rank
PE 22.59
Fwd PE 28.43
P/S 1.79
P/FCF 20.81
P/OCF 13.96
P/B 2.09
P/tB 2.09
EV/EBITDA 17.02
EPS(TTM)2.51
EY4.43%
EPS(NY)1.99
Fwd EY3.52%
FCF(TTM)2.72
FCFY4.81%
OCF(TTM)4.06
OCFY7.16%
SpS31.67
BVpS27.12
TBVpS27.12
PEG (NY)N/A
PEG (5Y)N/A
Graham Number39.1383 (-30.97%)
Profitability
Industry RankSector Rank
ROA 16.03%
ROE 18.62%
ROCE 6.28%
ROIC 5.75%
ROICexc 9.27%
ROICexgc 9.27%
OM 5.59%
PM (TTM) 15.95%
GM 85.39%
FCFM 8.61%
ROA(3y)6.51%
ROA(5y)-0.53%
ROE(3y)7.56%
ROE(5y)-0.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.64%
GM growth 5Y0.15%
F-Score7
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 275.84%
Cap/Sales 4.22%
Interest Coverage 371.93
Cash Conversion 180.21%
Profit Quality 53.97%
Current Ratio 6.08
Quick Ratio 4.56
Altman-Z 9.3
F-Score7
WACC9.03%
ROIC/WACC0.64
Cap/Depr(3y)567.8%
Cap/Depr(5y)515.09%
Cap/Sales(3y)4.29%
Cap/Sales(5y)3.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.87%
EPS Next Y-20.55%
EPS Next 2Y2.59%
EPS Next 3Y11.8%
EPS Next 5Y14.64%
Revenue 1Y (TTM)13.6%
Revenue growth 3Y30.76%
Revenue growth 5Y51.2%
Sales Q2Q%12.25%
Revenue Next Year6.34%
Revenue Next 2Y7.23%
Revenue Next 3Y8.22%
Revenue Next 5Y8.47%
EBIT growth 1Y41.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year682.44%
EBIT Next 3Y112.89%
EBIT Next 5Y62.93%
FCF growth 1Y-13.88%
FCF growth 3Y216.73%
FCF growth 5YN/A
OCF growth 1Y-10.19%
OCF growth 3Y116.23%
OCF growth 5YN/A

INSPIRE MEDICAL SYSTEMS INC / INSP Fundamental Analysis FAQ

What is the ChartMill fundamental rating of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

ChartMill assigns a fundamental rating of 6 / 10 to INSP.


Can you provide the valuation status for INSPIRE MEDICAL SYSTEMS INC?

ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.


What is the profitability of INSP stock?

INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for INSP stock?

The Earnings per Share (EPS) of INSPIRE MEDICAL SYSTEMS INC (INSP) is expected to decline by -20.55% in the next year.